Axsome Therapeutics, Inc.
Biopharma company developing novel therapies for central nervous system (CNS) conditions.
AXSM | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- ONE WORLD TRADE CENTER, 29TH FLOOR, 10007 NEW YORK
- Website:
- https://www.axsome.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Axsome Therapeutics, Inc. is a biopharmaceutical company that develops and commercializes novel therapies for central nervous system (CNS) conditions. The company focuses on addressing unmet medical needs for disorders that have limited treatment options. Its development pipeline targets a range of CNS conditions, including depression, Alzheimer's disease agitation, migraine, narcolepsy, and fibromyalgia. Axsome is committed to developing innovative products to meaningfully improve the lives of patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Axsome Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Axsome Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Axsome Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
